Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Februar 2026 19:53 ET | Quelle: PharmaZee

PharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026

PharmaZee telehealth platform information updated. Examining compounded vs FDA-approved GLP-1s amid Novo Nordisk compounding statement Feb 2026.
28. Januar 2026 18:03 ET | Quelle: TomorrowRX

TomorrowsRx Telehealth Service Outlines Prescription Access for Compounded Semaglutide and Advanced Tirzepatide Formulations

TomorrowsRx platform details prescription access process for compounded semaglutide & tirzepatide formulations through telehealth evaluation.
22. Januar 2026 19:50 ET | Quelle: SynergyRx

Cheapest Compounded Semaglutide Without Insurance in 2026: What "Low-Cost" GLP-1 Pricing Often Excludes — SynergyRx Consumer Analysis

Cheapest Compounded Semaglutide without insurance 2026: What low-cost GLP-1 pricing often excludes from total monthly cost—consumer framework.
19. Dezember 2025 23:13 ET | Quelle: MEDVI

Is MEDVi the Best GLP-1 Supplier for 2026? Platform Lists Compounded Semaglutide at $179/Month With No Contract Ahead of Weight Loss Season

MEDVi lists compounded GLP-1 injections at $179 first month, $299 refills as 100,000+ patients seek affordable semaglutide ahead of 2026 New Year.